Aeglea BioTherapeutics
potential for further upside if sub optimal dosing of first generation anti a identified ass leet | Aeglea BioTherapeutics
Deck date
June 2023
Slide
33 of 50
Other recent decks by Aeglea BioTherapeutics
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io